1. Home
  2. HFFG vs CRVS Comparison

HFFG vs CRVS Comparison

Compare HFFG & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HF Foods Group Inc.

HFFG

HF Foods Group Inc.

HOLD

Current Price

$2.13

Market Cap

127.8M

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$7.08

Market Cap

546.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HFFG
CRVS
Founded
1997
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Food Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
127.8M
546.7M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
HFFG
CRVS
Price
$2.13
$7.08
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$13.75
AVG Volume (30 Days)
116.4K
1.7M
Earning Date
11-10-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,225,541,000.00
N/A
Revenue This Year
$4.36
N/A
Revenue Next Year
$3.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.10
N/A
52 Week Low
$1.70
$2.54
52 Week High
$4.93
$9.60

Technical Indicators

Market Signals
Indicator
HFFG
CRVS
Relative Strength Index (RSI) 37.17 40.37
Support Level $2.10 $6.43
Resistance Level $2.29 $7.81
Average True Range (ATR) 0.12 0.46
MACD -0.02 -0.10
Stochastic Oscillator 5.36 40.00

Price Performance

Historical Comparison
HFFG
CRVS

About HFFG HF Foods Group Inc.

HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: